GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $932,000 | -1.0% | 21,416 | -0.9% | 0.10% | +15.9% |
| Q1 2022 | $941,000 | -0.2% | 21,601 | +1.0% | 0.08% | 0.0% |
| Q4 2021 | $943,000 | +14.0% | 21,383 | -1.3% | 0.08% | +9.3% |
| Q3 2021 | $827,000 | -4.1% | 21,655 | +0.0% | 0.08% | -1.3% |
| Q2 2021 | $862,000 | +4.4% | 21,647 | -6.5% | 0.08% | -3.8% |
| Q1 2021 | $826,000 | -2.9% | 23,155 | +0.1% | 0.08% | -11.2% |
| Q4 2020 | $851,000 | -2.4% | 23,125 | -0.2% | 0.09% | -16.8% |
| Q3 2020 | $872,000 | -7.3% | 23,167 | +0.4% | 0.11% | -23.6% |
| Q2 2020 | $941,000 | +267.6% | 23,070 | +265.3% | 0.14% | +418.5% |
| Q3 2017 | $256,000 | +10.3% | 6,315 | +17.2% | 0.03% | +3.8% |
| Q2 2017 | $232,000 | +1.3% | 5,389 | -0.7% | 0.03% | 0.0% |
| Q1 2017 | $229,000 | +90.8% | 5,429 | +74.0% | 0.03% | +225.0% |
| Q3 2015 | $120,000 | – | 3,121 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |